439 related articles for article (PubMed ID: 27927190)
1. CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care-a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999-2013.
Zeitlmann N; Gunsenheimer-Bartmeyer B; Santos-Hövener C; Kollan C; An der Heiden M;
BMC Infect Dis; 2016 Dec; 16(1):739. PubMed ID: 27927190
[TBL] [Abstract][Full Text] [Related]
2. Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.
de Monteynard LA; Dray-Spira R; de Truchis P; Grabar S; Launay O; Meynard JL; Khuong-Josses MA; Gilquin J; Rey D; Simon A; Pavie J; Mahamat A; Matheron S; Costagliola D; Abgrall S;
PLoS One; 2015; 10(3):e0118492. PubMed ID: 25734445
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology of HIV and AIDS reports in migrants in the 27 European Union countries, Norway and Iceland: 1999-2006.
Del Amo J; Likatavičius G; Pérez-Cachafeiro S; Hernando V; González C; Jarrín I; Noori T; Hamers FF; Bolúmar F
Eur J Public Health; 2011 Oct; 21(5):620-6. PubMed ID: 21051469
[TBL] [Abstract][Full Text] [Related]
4. Impact of HIV knowledge and stigma on the uptake of HIV testing - Results from a community-based participatory research survey among migrants from sub-Saharan Africa in Germany.
Kuehne A; Koschollek C; Santos-Hövener C; Thorlie A; Müllerschön J; Mputu Tshibadi C; Mayamba P; Batemona-Abeke H; Amoah S; Wangare Greiner V; Dela Bursi T; Bremer V
PLoS One; 2018; 13(4):e0194244. PubMed ID: 29641527
[TBL] [Abstract][Full Text] [Related]
5. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
HIV Med; 2018 Jan; 19(1):42-48. PubMed ID: 28741837
[TBL] [Abstract][Full Text] [Related]
6. Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.
Pantazis N; Morrison C; Amornkul PN; Lewden C; Salata RA; Minga A; Chipato T; Jaffe H; Lakhi S; Karita E; Porter K; Meyer L; Touloumi G;
PLoS One; 2012; 7(3):e32369. PubMed ID: 22412867
[TBL] [Abstract][Full Text] [Related]
7. Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?
Gatey C; Brun A; Hamet G; Diamantis S; Sellier P; Bouchaud O; Garrait V; Rozenbaum W; Molina JM; Abgrall S;
HIV Med; 2019 Feb; 20(2):175-181. PubMed ID: 30506853
[TBL] [Abstract][Full Text] [Related]
8. Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.
Staehelin C; Rickenbach M; Low N; Egger M; Ledergerber B; Hirschel B; D'Acremont V; Battegay M; Wagels T; Bernasconi E; Kopp C; Furrer H;
AIDS; 2003 Oct; 17(15):2237-44. PubMed ID: 14523281
[TBL] [Abstract][Full Text] [Related]
9. Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe.
Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
AIDS; 2017 Mar; 31(6):835-846. PubMed ID: 28272136
[TBL] [Abstract][Full Text] [Related]
10. Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain.
Monge S; Alejos B; Dronda F; Del Romero J; Iribarren JA; Pulido F; Rubio R; Miró JM; Gutierrez F; Del Amo J;
HIV Med; 2013 May; 14(5):273-83. PubMed ID: 23171059
[TBL] [Abstract][Full Text] [Related]
11. Impact of health insurance status among migrants from sub-Saharan Africa on access to health care and HIV testing in Germany: a participatory cross-sectional survey.
Müllerschön J; Koschollek C; Santos-Hövener C; Kuehne A; Müller-Nordhorn J; Bremer V
BMC Int Health Hum Rights; 2019 Mar; 19(1):10. PubMed ID: 30832665
[TBL] [Abstract][Full Text] [Related]
12. Gaps in the HIV diagnosis and care cascade for migrants in Australia, 2013-2017: A cross-sectional study.
Marukutira T; Gray RT; Douglass C; El-Hayek C; Moreira C; Asselin J; Donovan B; Vickers T; Spelman T; Crowe S; Guy R; Stoove M; Hellard M
PLoS Med; 2020 Mar; 17(3):e1003044. PubMed ID: 32155145
[TBL] [Abstract][Full Text] [Related]
13. [HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)].
Caro-Murillo AM; Gutiérrez F; Manuel Ramos J; Sobrino P; Miró JM; López-Cortés LF; Tural C; Moreno A; de Los Santos I; Murillas J; Camino X; Salavert M; Rubio R; Moreno S; del Amo J;
Enferm Infecc Microbiol Clin; 2009; 27(7):380-8. PubMed ID: 19427080
[TBL] [Abstract][Full Text] [Related]
14. Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives.
Seng R; Ghislain M; Girard PM; Cotte L; Meybeck A; Raffi F; Abgrall S; Yazdanpanah Y; Goujard C; Dray-Spira R; Meyer L
AIDS; 2017 Jun; 31(9):1323-1332. PubMed ID: 28492394
[TBL] [Abstract][Full Text] [Related]
15. Determinants of HIV, viral hepatitis and STI prevention needs among African migrants in Germany; a cross-sectional survey on knowledge, attitudes, behaviors and practices.
Santos-Hövener C; Marcus U; Koschollek C; Oudini H; Wiebe M; Ouedraogo OI; Thorlie A; Bremer V; Hamouda O; Dierks ML; An der Heiden M; Krause G
BMC Public Health; 2015 Aug; 15():753. PubMed ID: 26246382
[TBL] [Abstract][Full Text] [Related]
16. Travel-related health events and their risk factors in HIV-infected sub-Saharan migrants living in France and visiting their native country: The ANRS VIHVO cohort study.
Pistone T; Ouattara E; Gabillard D; Lele N; Duvignaud A; Cordel H; Malvy D; Bouchaud O; Abgrall S;
Travel Med Infect Dis; 2019; 29():40-47. PubMed ID: 30951905
[TBL] [Abstract][Full Text] [Related]
17. Late presentation for HIV diagnosis and care in Germany.
Zoufaly A; an der Heiden M; Marcus U; Hoffmann C; Stellbrink H; Voss L; van Lunzen J; Hamouda O;
HIV Med; 2012 Mar; 13(3):172-81. PubMed ID: 22093171
[TBL] [Abstract][Full Text] [Related]
18. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.
Siedner MJ; Ng CK; Bassett IV; Katz IT; Bangsberg DR; Tsai AC
Clin Infect Dis; 2015 Apr; 60(7):1120-7. PubMed ID: 25516189
[TBL] [Abstract][Full Text] [Related]
19. Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France.
de Monteynard LA; Matheron S; Gilquin J; Pavie J; de Truchis P; Grabar S; Launay O; Meynard JL; Khuong-Josses MA; Rey D; Simon A; Mahamat A; Dray-Spira R; Costagliola D; Abgrall S;
AIDS; 2016 Sep; 30(14):2235-46. PubMed ID: 27428741
[TBL] [Abstract][Full Text] [Related]
20. Monitoring progress towards the first UNAIDS 90-90-90 target in key populations living with HIV in Norway.
Whittaker R; Case KK; Nilsen Ø; Blystad H; Cowan S; Kløvstad H; van Sighem A
BMC Infect Dis; 2020 Jun; 20(1):451. PubMed ID: 32590964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
